The Confocal and Specialized Microscopy Shared Resource is a fully Cancer Center-managed facility.Subcellular imaging is an essential tool in cancer biology. However, although the ideal specimen forconventional optical microscopy is two-dimensional, biological material is organized in three dimensions.Several technologies, notably confocal microscopy, are available to collect 3D images of biologicalsamples, with a spatial resolution superior to conventional microscopy. These essential imaging systemsare expensive and difficult for inexperienced users to operate and maintain, and are not routinely availablein individual research laboratory. The services provided by the Confocal and Specialized MicroscopyShared Resource are: one-photon laser scanning confocal microscopy multiphoton excitation confocal microscopy spinning-disk confocal microscopy digital deconvolution microscopyAll of these 3-dimensional fluorescence imaging technologies are made conveniently and affordablyavailable to HICCC members and other Columbia University researchers in a centralized facility, withtraining, assisted use, and consultation on data analysis and presentation provided by a full-time employeeand a manager. Since 1996, the facility has been used by more than 154 principal investigators from over30 basic science and clinical departments at Columbia University, and has contributed images for more200 publications. The facility is currently used at 75% of its maximal capacity during peak hours. InJanuary 2007, the facility moved into newly renovated space in the Irving Cancer Research Center. Thefacility continually seeks to add new imaging technologies to meet the scientific needs of our users. Inconjunction with the HICCC, we will introduce a new confocal microscope in the next year.During the last period of the CCSG, 37% of the users have been Cancer Center members with peerreviewedfunding, with those members representing 26% of the hours used in the facilty. The totaloperating budget of the facility is $273,025, of which we are requesting $79,749 from the CCSG.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA013696-35
Application #
7669912
Study Section
Subcommittee G - Education (NCI)
Project Start
2008-08-01
Project End
2013-06-30
Budget Start
2008-08-01
Budget End
2009-06-30
Support Year
35
Fiscal Year
2008
Total Cost
$70,104
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Sones, Jennifer L; Merriam, Audrey A; Seffens, Angelina et al. (2018) Angiogenic factor imbalance precedes complement deposition in placentae of the BPH/5 model of preeclampsia. FASEB J 32:2574-2586
Park, Karen Sophia; Xu, Christine L; Cui, Xuan et al. (2018) Reprogramming the metabolome rescues retinal degeneration. Cell Mol Life Sci 75:1559-1566
Mumau, Melanie D; Vanderbeck, Ashley N; Lynch, Elizabeth D et al. (2018) Identification of a Multipotent Progenitor Population in the Spleen That Is Regulated by NR4A1. J Immunol 200:1078-1087
Caviglia, Jorge Matias; Yan, Jun; Jang, Myoung-Kuk et al. (2018) MicroRNA-21 and Dicer are dispensable for hepatic stellate cell activation and the development of liver fibrosis. Hepatology 67:2414-2429
Savage, Thomas M; Shonts, Brittany A; Obradovic, Aleksandar et al. (2018) Early expansion of donor-specific Tregs in tolerant kidney transplant recipients. JCI Insight 3:
Wu, Wen-Hsuan; Tsai, Yi-Ting; Justus, Sally et al. (2018) CRISPR Repair Reveals Causative Mutation in a Preclinical Model of Retinitis Pigmentosa: A Brief Methodology. Methods Mol Biol 1715:191-205
Jauregui, Ruben; Park, Karen Sophia; Tsang, Stephen H (2018) Two-year progression analysis of RPE65 autosomal dominant retinitis pigmentosa. Ophthalmic Genet 39:544-549
Yen, Bonnie; Fortson, Katherine T; Rothman, Nyanza J et al. (2018) Clonal Bifurcation of Foxp3 Expression Visualized in Thymocytes and T Cells. Immunohorizons 2:119-128
Ishida, Chiaki T; Zhang, Yiru; Bianchetti, Elena et al. (2018) Metabolic Reprogramming by Dual AKT/ERK Inhibition through Imipridones Elicits Unique Vulnerabilities in Glioblastoma. Clin Cancer Res 24:5392-5406
Jin, Chun-Hui; Li, Yang; Xia, Jinxing et al. (2018) CXCR4 blockade improves leukemia eradication by allogeneic lymphocyte infusion. Am J Hematol 93:786-793

Showing the most recent 10 out of 331 publications